Immunocytochemistry of phospholipase D1 and D2 in cultured cells

被引:2
|
作者
Hozumi, Yasukazu [1 ,3 ]
Yamazaki, Masakazu [1 ]
Nakano, Tomoyuki [2 ]
机构
[1] Akita Univ, Grad Sch Med, Dept Cell Biol & Morphol, Akita 0108543, Japan
[2] Yamagata Univ, Sch Med, Dept Anat & Cell Biol, Yamagata 9909585, Japan
[3] Akita Univ, Grad Sch Med, Dept Cell Biol & Morphol, Hondo 1-1-1, Akita 0108543, Japan
基金
日本学术振兴会;
关键词
3T3-L1; cell; Immunocytochemistry; NIH3T3; Short interfering RNA; Specific antibody; PROTEIN-KINASE-C; ADP-RIBOSYLATION FACTOR; DIACYLGLYCEROL KINASE; PHOSPHATIDIC-ACID; ALPHA-THROMBIN; ISOFORM; STIMULATION; LOCALIZES; ENZYMES; BIOLOGY;
D O I
10.1016/j.bbrc.2022.07.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of Gq protein-coupled receptors triggers the phospholipase C (PLC) pathway, which yields a pair of second messengers: diacylglycerol (DG) and inositol 1,4,5-trisphosphate (IP3). DG kinase (DGK) phosphorylates DG to produce phosphatidic acid (PA), which serves as another second messenger. Along with PLC-DGK pathway, PA is produced directly by the action of phospholipase D (PLD), which hydrolyzes the major membrane phospholipid: phosphatidylcholine (PC). PA is converted to DG by phosphatidic acid phosphatase, suggesting that PLD, together with DGK, is a key enzyme regulating DG and PA. PLD has been implicated in a broad range of cellular processes. However, cellular expression and subcellular localization of PLD remain elusive because of a lack of specific antibodies against PLDs. For this study, we raised specific antibodies against major mammalian PLD isoforms: PLD1 and PLD2. Immunocytochemical analysis using specific antibodies showed clearly that native PLD1 and PLD2 localize to distinct subcellular regions as dot-like structures in cultured cells. PLD1 predominantly localizes to the plasma membrane, whereas PLD2 mostly localizes within the cytoplasm. These findings suggest that PLD1 and PLD2 have different roles in the phosphoinositide signaling pathway in distinct subcellular regions. (C) 2022 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [31] INTERACTION OF FLUNARIZINE WITH DOPAMINE D2 AND D1 RECEPTORS
    AMBROSIO, C
    STEFANINI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 197 (2-3) : 221 - 223
  • [32] CLOZAPINE AND D1/D2 ANTAGONISM IN EXTRAPYRAMIDAL FUNCTIONS
    GERLACH, J
    HANSEN, L
    BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 : 34 - 37
  • [33] D1 versus D2 lymphadenectomy for gastric cancer
    Schmidt, Benjamin
    Yoon, Sam S.
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (03) : 259 - 264
  • [34] Simultaneous Lasing on the D1 and D2 Lines of Sodium
    Hewitt, J. D.
    Eden, J. G.
    2012 CONFERENCE ON LASERS AND ELECTRO-OPTICS (CLEO), 2012,
  • [35] Phospholipase D2 in caveolae
    Oh, P
    Oh, P
    Liscovitch, M
    Schnitzer, JE
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 122A - 122A
  • [36] D-TYPE CYCLINS (D1, D2, AND D3)
    不详
    HYBRIDOMA, 1994, 13 (01): : 79 - 79
  • [37] Ceramide inhibition of mammalian phospholipase D1 and D2 activities is antagonized by phosphatidylinositol 4,5-bisphosphate
    Singh, IN
    Stromberg, LM
    Bourgoin, SG
    Sciorra, VA
    Morris, AJ
    Brindley, DN
    BIOCHEMISTRY, 2001, 40 (37) : 11227 - 11233
  • [38] Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase Cγ and protein kinase Cα signalling cascade
    Slaaby, R
    Du, GW
    Altshuller, YM
    Frohman, MA
    Seedorf, K
    BIOCHEMICAL JOURNAL, 2000, 351 (03) : 613 - 619
  • [39] Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells
    Matthews, Sharon A.
    Navarro, Maria N.
    Sinclair, Linda V.
    Emslie, Elizabeth
    Feijoo-Carnero, Carmen
    Cantrell, Doreen A.
    BIOCHEMICAL JOURNAL, 2010, 432 : 153 - 163
  • [40] Effect of clozapine on doparnine D1 and D2 receptors interaction in the HEK 293 cells
    Faron-Gorecka, A.
    Gorecki, A.
    Kusmider, M.
    Wasylewski, Z.
    Dziedzicka-Wasylewska, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S25 - S26